Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
Public ClinicalTrials.gov record NCT02109562. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety and Tolerability of RBP-7000 as a Treatment in Subjects With Acute Schizophrenia Over 8 Weeks (2 Subcutaneous Doses)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the efficacy and safety of RBP-7000 compared with placebo in the treatment of patients with schizophrenia. This will be a double-blind, placebo-controlled, Phase III study with 90 mg and 120 mg doses of RBP-7000 compared with placebo over an 8-week treatment period.
Study identification
- NCT ID
- NCT02109562
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 354 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 55 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2014 (Type not available)
- Primary completion
- Nov 2014 (Actual)
- Completion
- Nov 2014 (Actual)
- Last update posted
- Oct 26, 2018
2014
United States locations
- U.S. sites
- 32
- U.S. states
- 15
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Woodland International Research Group, Inc. | Little Rock | Arkansas | 72211 | — |
| Woodland International Research Group, Inc. | Springdale | Arkansas | 72764 | — |
| Comprehensive Clinical Development - Cerritos, CA | Cerritos | California | 90703 | — |
| Synergy Clinical Research of Escondido | Escondido | California | 92025 | — |
| Behavioral Research Specialists, LLC | Glendale | California | 91206 | — |
| Collaborative Neuroscience Networks, Inc. | Long Beach | California | 90806 | — |
| Apostle Clinical Trials, Inc. | Long Beach | California | 90813 | — |
| Pacific Research Partners | Oakland | California | 94612 | — |
| Excell Research, Inc. | Oceanside | California | 92056 | — |
| CNRI- Los Angeles, LLC | Pico Rivera | California | 90660 | — |
| CNRI - San Diego, LLC | San Diego | California | 92012 | — |
| Innovative Clinical Research | Fort Lauderdale | Florida | 33308 | — |
| Behavioral Clinical Research, Inc. | North Miami | Florida | 33021 | — |
| Florida Clinical Research Center, LLC | Orlando | Florida | 32751 | — |
| Uptown Research Institute | Chicago | Illinois | 60640 | — |
| Alexian Brothers Behavioral Health Hospital | Hoffman Estates | Illinois | 60169 | — |
| Via Christi Research | Wichita | Kansas | 67214 | — |
| Lake Charles Clinical Trials, LLC | Lake Charles | Louisiana | 70629 | — |
| J. Gary Booker, MD, APMC | Shreveport | Louisiana | 71104-2136 | — |
| St. Louis Clinical Trials | St Louis | Missouri | 63118 | — |
| PsychCare Consultants Research | St Louis | Missouri | 63128 | — |
| Altea Research Institute | Las Vegas | Nevada | 89102 | — |
| CRI Lifetree | Marlton | New Jersey | 08053 | — |
| Neurobehavioral Research, Inc. | Cedarhurst | New York | 11516 | — |
| New Hope Clinical Research | Charlotte | North Carolina | 28204 | — |
| Midwest Clinical Research Center, LLC | Dayton | Ohio | 45417 | — |
| Oklahoma Clinical Research Center | Oklahoma City | Oklahoma | 73112 | — |
| CRI Lifetree | Philadelphia | Pennsylvania | 19139 | — |
| FutureSearch Clinical Trials, L.P. | Austin | Texas | 78734 | — |
| Community Clinical Research, Inc. | Austin | Texas | 78754 | — |
| FutureSearch Clinical Trials, L.P. | Dallas | Texas | 75231 | — |
| Pillar Clinic Research, LLC | Dallas | Texas | 75243 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02109562, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 26, 2018 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02109562 live on ClinicalTrials.gov.